Skip to content

Effect of Acute Dietary Supplementation With Grape Seed Extract on Aortic Stiffness, Arterial Pressure, and Blood Vessel Dilation in Collegiate Obese Individuals at Rest

Effects of Acute Grape Seed Extract Supplementation on Hemodynamics in Obese Males

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04389060
Enrollment
20
Registered
2020-05-15
Start date
2019-03-01
Completion date
2020-03-01
Last updated
2020-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

This study investigated if elevated BP and aortic stiffness characterized in obese individuals are attenuated following acute grape seed extract supplementation. It is hypothesized that acute dietary supplementation with grape seed extract attenuates aortic stiffness, systolic blood pressure, diastolic blood pressure, mean arterial pressure, and total peripheral resistance and these effects are partially due to reductions in peripheral vasoconstriction

Detailed description

Twenty men (obese = 10; normal body weight (NBW) = 10) participated in this study. Effects of placebo (PL: 600 mg) and GSE (600 mg) on systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate (HR), stroke volume (SV), cardiac output (Q), total peripheral resistance (TPR), and AoS were compared 2 h after ingestion of GSE or PL on different days, one week apart. Arterial blood pressure was measured using a sphygmomanometer from a brachial artery at the level of the heart on chair. HR and SV were continuously measured using a non-invasive device (Physio Flow). CO was calculated by HR X SV. TPR was calculated by MAP/CO.

Interventions

DIETARY_SUPPLEMENTGrape seed extract

Two capsule grape seed extract (total 600 mg)

Sponsors

California Baptist University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Masking description

Double blind, cross-over design

Eligibility

Sex/Gender
MALE
Age
18 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Obesity: body mass index (\>30), Normal body weight: body mass index (25-29)

Exclusion criteria

* cardiovascular diseases or consume any antihypertensive medication or supplementation that can affect blood pressure or aortic stiffness

Design outcomes

Primary

MeasureTime frameDescription
change in heart rate2 hours after each supplementationbeats per minute
change in stroke volume2 hours after each supplementationvolume per stroke
change in cardiac output2 hours after each supplementationtotal volume for a minute
change in systolic blood pressure2 hours after each supplementationpressure exerted during contraction
change in diastolic blood pressure2 hours after each supplementationpressure exerted during relaxation
change in mean arterial pressure2 hours after each supplementationOne reported pressure (systolic blood pressure-diastolic blood pressure)/3 + diastolic blood pressure
change in total peripheral resistance2 hours after each supplementationOne reported value (mean arterial pressure/cardiac output)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026